← All stocks

MRK vs NVS

Merck & Company Inc. Common Stock (new) vs Novartis AG Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

MRK
Merck & Company Inc. Common Stock (new)
Healthcare
146.87
362.35B
NVS
Novartis AG Common Stock
Healthcare
140.37
266.80B
ACCE scores
MRK
NVS
Composite score
Out of 100
54
58
Growth
28
19
Value
39
68
Quality
50
96
Momentum
97
47
Valuation
MRK
NVS
Price
146.87
140.37
Market cap
362.35B
266.80B
Trailing P/E
117.50
21.17
Forward P/E
15.15
14.47
EV / EBITDA
28.40
13.65
Dividend yield
2.3%
3.4%
Profitability
MRK
NVS
ROE
7.0%
30.3%
Net margin
4.8%
22.5%
Debt / equity
0.94
0.73
Free cash flow
12.36B
17.69B
Growth
MRK
NVS
Revenue growth (YoY)
5.1%
0.8%
Earnings growth (YoY)
-19.3%
-17.0%
Analyst target
152.96
156.56
See full analysis